Back to User profile » Dr Hongliang Wang

Papers published by Dr Hongliang Wang:

Original Research

Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase

Wang L, Li Q, Yan H, Jiao G, Wang H, Chi H, Zhou H, Chen L, Shan Y, Chen Y

Drug Design, Development and Therapy 2020, 14:4451-4463

Published Date: 23 October 2020

Original Research

Up-Regulation of Hsa_circ_0008792 Inhibits Osteosarcoma Cell Invasion and Migration and Promotes Apoptosis by Regulating Hsa-miR-711/ZFP1

Chen L, Shan Y, Zhang H, Wang H, Chen Y

OncoTargets and Therapy 2020, 13:2173-2181

Published Date: 11 March 2020

Original Research

miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways

Zhang S, Li D, Jiao G, Wang H, Yan T

OncoTargets and Therapy 2018, 11:7967-7977

Published Date: 9 November 2018